Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesMolecular ImagingSNMMI: Dual-targeting radioligand therapy safe for several cancersA new "dual-targeting" radioligand therapy has been shown to be safe and effective in humans.Molecular ImagingVideo from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelinesMolecular ImagingSNMMI: Dual PET/MRI technique could help manage primary aldosteronismMolecular ImagingSNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patientsSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
